ARD1A antibody
GTX125971
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse
TargetNAA10
Overview
- SupplierGeneTex
- Product NameARD1A antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.73 mg/ml
- ConjugateUnconjugated
- Gene ID8260
- Target nameNAA10
- Target descriptionN-alpha-acetyltransferase 10, NatA catalytic subunit
- Target synonymsARD1; ARD1 homolog A, N-acetyltransferase; ARD1A; ARD1P; arrest defective protein 1; DXS707; hARD1; MCOPS1; N-acetyltransferase ARD1, human homolog of; N-alpha-acetyltransferase 10; natA catalytic subunit Naa10; NATD; N-terminal acetyltransferase complex ARD1 subunit homolog A; OGDNS; TE2
- HostRabbit
- IsotypeIgG
- Protein IDP41227
- Protein NameN-alpha-acetyltransferase 10
- Scientific DescriptionN-alpha-acetylation is one of the most common protein modifications that occurs during protein synthesis and involves the transfer of an acetyl group from acetyl-coenzyme A to the protein alpha-amino group. ARD1A, together with NATH (NARG1; MIM 608000), is part of a major N-alpha-acetyltransferase complex responsible for alpha-acetylation of proteins and peptides (Sanchez-Puig and Fersht, 2006 [PubMed 16823041]).[supplied by OMIM]
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Metagenomic characterization of lysine acetyltransferases in human cancer and their association with clinicopathologic features. Jiang Y et al., 2020 May, Cancer SciRead more
- The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK. Takekoshi D et al., 2019 May, In Vitro Cell Dev Biol AnimRead more
- Reducing Tumour Hypoxia via Oral Administration of Oxygen Nanobubbles. Owen J et al., 2016, PLoS OneRead more